| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 肠外营养系(元) | 206,453,210.64 | 511,933,421.29 | 256,683,503.66 | 615,221,192.95 | 277,443,433.40 |
| 服务收入(元) | - | - | 164,047,857.12 | 413,766,347.53 | 133,050,937.59 |
| 肝胆消化(元) | - | - | - | 67,002,251.58 | 30,799,629.01 |
| 抗生素(元) | - | - | - | 118,896,746.80 | 49,933,797.25 |
| 麻醉产品(元) | 796,479,421.25 | 1,231,651,885.28 | 517,198,642.10 | 849,666,633.50 | 342,656,667.79 |
| 心脑血管(元) | - | - | - | 67,488,953.83 | 26,627,878.79 |
| 原料药(元) | - | - | 317,029,880.69 | 569,779,722.75 | 237,589,188.65 |
| 肿瘤止吐(元) | 163,115,730.89 | 305,420,471.07 | 136,040,511.80 | 211,715,078.81 | 67,553,855.10 |
| 合作产品相关收入(元) | 471,917,438.75 | 943,165,709.63 | - | - | - |
| 其他产品(元) | 340,477,029.81 | 580,472,122.67 | 282,150,206.20 | 421,596,915.82 | 194,927,930.96 |
| 其他(元) | 5,215,083.02 | 120,100,758.58 | - | - | - |
| 营业成本(元) | |||||
| 肠外营养系(元) | 90,701,877.17 | 208,270,885.07 | 103,717,622.41 | 241,248,829.07 | 105,601,302.58 |
| 服务收入(元) | - | - | 77,478,544.50 | 167,676,015.77 | 63,678,503.17 |
| 肝胆消化(元) | - | - | - | 30,001,215.01 | 9,269,168.29 |
| 抗生素(元) | - | - | - | 30,172,493.44 | 11,456,656.58 |
| 麻醉产品(元) | 64,237,585.69 | 117,876,830.57 | 53,302,198.53 | 85,497,718.34 | 19,851,799.91 |
| 心脑血管(元) | - | - | - | 23,563,760.27 | 6,614,297.76 |
| 原料药(元) | - | - | 106,319,012.47 | 210,936,630.49 | 115,165,286.93 |
| 肿瘤止吐(元) | 19,468,736.16 | 39,732,253.51 | 20,669,080.58 | 33,878,809.42 | 10,046,846.22 |
| 合作产品相关收入(元) | 235,348,358.24 | 410,019,623.87 | - | - | - |
| 其他产品(元) | 121,455,766.06 | 220,292,338.37 | 104,898,519.19 | 136,240,289.65 | 45,488,826.99 |
| 其他(元) | 1,414,302.85 | 51,868,357.40 | - | - | - |
| 毛利(元) | |||||
| 肠外营养系(元) | 115,751,333.47 | 303,662,536.22 | 152,965,881.25 | 373,972,363.88 | 171,842,130.82 |
| 服务收入(元) | - | - | 86,569,312.62 | 246,090,331.76 | 69,372,434.42 |
| 肝胆消化(元) | - | - | - | 37,001,036.57 | 21,530,460.72 |
| 抗生素(元) | - | - | - | 88,724,253.36 | 38,477,140.67 |
| 麻醉产品(元) | 732,241,835.56 | 1,113,775,054.71 | 463,896,443.57 | 764,168,915.16 | 322,804,867.88 |
| 心脑血管(元) | - | - | - | 43,925,193.56 | 20,013,581.03 |
| 原料药(元) | - | - | 210,710,868.22 | 358,843,092.26 | 122,423,901.72 |
| 肿瘤止吐(元) | 143,646,994.73 | 265,688,217.56 | 115,371,431.22 | 177,836,269.39 | 57,507,008.88 |
| 合作产品相关收入(元) | 236,569,080.51 | 533,146,085.76 | - | - | - |
| 其他产品(元) | 219,021,263.75 | 360,179,784.30 | 177,251,687.01 | 285,356,626.17 | 149,439,103.97 |
| 其他(元) | 3,800,780.17 | 68,232,401.18 | - | - | - |
| 毛利率(%) | |||||
| 肠外营养系(%) | 56.07 | 59.32 | 59.59 | 60.79 | 61.94 |
| 服务收入(%) | - | - | 52.77 | 59.48 | 52.14 |
| 肝胆消化(%) | - | - | - | 55.22 | 69.90 |
| 抗生素(%) | - | - | - | 74.62 | 77.06 |
| 麻醉产品(%) | 91.93 | 90.43 | 89.69 | 89.94 | 94.21 |
| 心脑血管(%) | - | - | - | 65.09 | 75.16 |
| 原料药(%) | - | - | 66.46 | 62.98 | 51.53 |
| 肿瘤止吐(%) | 88.06 | 86.99 | 84.81 | 84.00 | 85.13 |
| 合作产品相关收入(%) | 50.13 | 56.53 | - | - | - |
| 其他产品(%) | 64.33 | 62.05 | 62.82 | 67.68 | 76.66 |
| 其他(%) | 72.88 | 56.81 | - | - | - |
| 收入构成(%) | |||||
| 肠外营养系(%) | 10.41 | 13.86 | 15.34 | 18.45 | 20.39 |
| 服务收入(%) | - | - | 9.80 | 12.41 | 9.78 |
| 肝胆消化(%) | - | - | - | 2.01 | 2.26 |
| 抗生素(%) | - | - | - | 3.56 | 3.67 |
| 麻醉产品(%) | 40.15 | 33.35 | 30.91 | 25.48 | 25.18 |
| 心脑血管(%) | - | - | - | 2.02 | 1.96 |
| 原料药(%) | - | - | 18.95 | 17.08 | 17.46 |
| 肿瘤止吐(%) | 8.22 | 8.27 | 8.13 | 6.35 | 4.97 |
| 合作产品相关收入(%) | 23.79 | 25.54 | - | - | - |
| 其他产品(%) | 17.16 | 15.72 | 16.86 | 12.64 | 14.33 |
| 其他(%) | 0.26 | 3.25 | - | - | - |
| 毛利构成(%) | |||||
| 肠外营养系(%) | 7.98 | 11.48 | 12.68 | 15.74 | 17.65 |
| 服务收入(%) | - | - | 7.17 | 10.36 | 7.13 |
| 肝胆消化(%) | - | - | - | 1.56 | 2.21 |
| 抗生素(%) | - | - | - | 3.73 | 3.95 |
| 麻醉产品(%) | 50.46 | 42.11 | 38.44 | 32.16 | 33.16 |
| 心脑血管(%) | - | - | - | 1.85 | 2.06 |
| 原料药(%) | - | - | 17.46 | 15.10 | 12.58 |
| 肿瘤止吐(%) | 9.90 | 10.05 | 9.56 | 7.48 | 5.91 |
| 合作产品相关收入(%) | 16.30 | 20.16 | - | - | - |
| 其他产品(%) | 15.09 | 13.62 | 14.69 | 12.01 | 15.35 |
| 其他(%) | 0.26 | 2.58 | - | - | - |